Researchers at Brigham and Women’s Hospital and Massachusetts Institute of Technology have developed a new type of nanoparticle, which can be taken orally and gets successfully absorbed through the digestive tract. The nanoparticles ...
Tags: nanoparticle, Medicine
US-based pharmaceutical firm Egalet has entered into a definitive collaboration and license agreement with Japan-based Shionogi for the development and commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates ...
Tags: Egalet, Product Candidates
Silicone materials are widely used in Medical applications since from 60 years. Quickly after their Commercial availability in 1946, methylchlorosilanes were described to treat glassware to prevent blood from clotting. An effort was made by ...
Tags: application, FDA, grade, silicone, tubing
A recent research report cites 10 medical device technologies with significant growth potential that are valued at roughly $454.3 billion. The technologies include: 1. Diagnostic imaging, including nuclear imaging, interventional ...
US-based specialty pharmaceutical firm Impax Laboratories (Impax) has started shipment of generic Solaraze (diclofenac sodium gel, 3%), a first-to-file product, through its generics division Global Pharmaceuticals. In order to ...
The MedTech Industry's Premier Design Competition is now accepting entries. Proudly presented by UBM Canon and MD+DI , the Medical Design Excellence Awards program has provided market visibility to over 600 innovative medical products that ...
Particle Sciences, a drug delivery contract development and manufacturing organization, has been contracted by BHR Pharma to develop an in-field nasally applied formulation of progesterone for traumatic brain injury (TBI). BHR Pharma is ...
US-based Sagent Pharmaceuticals has introduced propofol injectable emulsion USP 1%, in two single-dose, single-patient vial presentations of 20mL and 100mL. The company said that a 50mL single-dose, single-patient vial presentation will ...
A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
Unilife, a US based manufacturer of injectable drug delivery systems, has announced an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to customize and supply devices from its platform of wearable ...
Professor Robert Langer, David H. Koch Institute Professor at the Massachusetts Institute of Technology, will be the honored speaker at the Axalta Distinguished Lectures sponsored by Axalta Coating Systems and hosted by the Department of ...
Tags: Robert Langer, speaker, Axalta, coating
US-based pharmaceutical firm Zogenix has entered into a development and option agreement (D&O Agreement) with Altus Formulation (Altus) to develop abuse deterrent formulations of Zohydro ER (hydrocodone bitartrate) extended-release ...
Tags: Zogenix, Zohydro ER
Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver ...
Tags: Cancer Drug, Medicine
Depomed, a US-based pharmaceutical firm, has launched Lazanda (fentanyl) nasal spray along with a new, dedicated team of regional sales specialists and the signature support program for patients with breakthrough cancer pain. Lazanda is ...
Tags: Lazanda Spray, Medicine
Pulmatrix has released positive results from initial stage of Phase IB clinical trial of a bronchodilator therapy PUR0200 for patients with chronic obstructive pulmonary disease (COPD). The company said PUR0200 is the first small molecule ...